Dong-Ah Ilbo

Nov 28, 2013

Life Sciences Going Beyond

With its latest adult stem cell treatment, Stem Cell Treatment & Research Institute (STRI) at STC Life has been successfully treating various nervous system related illnesses including Alzheimer and Parkinson’s diseases as well as stroke. Furthermore, STRI is also making continued progress in treating wider variety of illnesses including diabetes, arthritis, auto-immune diseases, injury of the vertebra and the nervous system, and facial nerve palsy.

Especially noteworthy is STC’s achievement in transforming Human Material Mesenchymal Stem Cells into Pluripotent Stem Cells using natural compound, for the first time ever in the world. The Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC -nEPS) developed by STC is free from ethical controversy as it is developed without using ovum or embryo and can be successfully differentiated into a neurocyte, chondrocyte, osteoblast, hepatocyte, and a lyparcyte published here. This innovation, expected to change the paradigm in the field of stem cell sciences, recently applied for patent registration in Korea and overseas and next step would be to develop treatments.

STC Life is also proposing proactive solution in the field of anti-ageing. Its researches in the gerontogene p62 enabled them to identify the causes and process of how ageing related illnesses including degenerative diseases and abdominal obesity occur.

Anti-ageing, Energy Water, and Cosmetics

Global anti-ageing market boasts high marketability that was estimated at 15 million US$ last year. STC is working on development of the control agent for the gerontogene p62 and when successful, this will earmark the treatment of senile diseases.

Energy Water business is also gradually bearing fruit. Energy Water is a functional water that controls on balance inside human body and triggers stabilizing function of the cells to improve metabolism. After continuing related research works since its opening in 1989, STC was able to come up with 2.5 times faster growth and harvest in their tests conducted at extreme weather conditions in the Philippines and China. Recent signing of MOU with a Chinese business partner to supply the product that can be applied for agricultural as well as industrial purposes is expected to bring increased revenue for STC.

▼Interview with Kye-ho Lee, Chairman of STC Life▼

‘Our Goal is to Emerge into a World Top 10 Bio Company’

“STC’s core projects – Stem Cell, Anti-Ageing and Energy Water are all directly associated with the next generation bio sciences. We’re making thorough preparation for the upcoming bio sciences revolution,” remarked Kye-ho Lee, Chairman of STC Life. Lee believes it is vital for a company to eye on the rapidly changing environment where life sciences is changing the paradigm in genes, agriculture, environment, food and even cosmetics.

STC developed Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC n-EPS) is receiving recognition for its innovation and the company’s stem cell growth factor product became the first to pass appraisal by an authorized agency. Furthermore, world’s first finding of the p62 gene to lead the anti-ageing market was another significant finding.

With a belief that progress of his company will contribute to development of Korea, Lee’s vision is wide-reaching. STC has already taken off with its research in stem cells and anti-ageing and based in this leadership initiative, will continue to emerge into a world leading bio company.